Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to MYPI20054949priorityCriticalpatent/MY144534A/en
Publication of MY144534ApublicationCriticalpatent/MY144534A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A MEDICAMENT COMPRISING, SEPARATELY OR TOGETHER (A) GLYCOPYRROLATE; AND (B) EITHER A COMPOUND OF FORMULA I IN FREE OR SALT OR SOLVATE FORM, WHEREIN W, RX RY, R1, R2, R3, R4, R5, R6 AND R7 HAVE THE MEANINGS AS INDICATED IN THE SPECIFICATION, OR A COMPOUND OF FORMULA II IN FREE OR SALT OR SOLVATE FORM, WHEREIN X HAS THE MEANING AS INDICATED IN THE SPECIFICATION, FOR SIMULTANEOUS, SEQUENTIAL OR SEPARATE ADMINISTRATION IN THE TREATMENT OF IN INFLAMMATORY OR OBSTRUCTIVE AIRWAYS DISEASE. PHARMACEUTICAL COMPOSITIONS THAT CONTAIN (A) AND (B) ARE ALSO DESCRIBED.
MYPI200549492005-10-212005-10-21Combinations of glycopyrrolate and beta2 adrenoceptor agonists
MY144534A
(en)